MUTAGENIC ACTIVATION OF AFLATOXIN-B1 BY PULMONARY, RENAL, AND HEPATIC CYTOCHROME-P450S FROM RATS

被引:25
|
作者
IMAOKA, S
IKEMOTO, S
SHIMADA, T
FUNAE, Y
机构
[1] OSAKA CITY UNIV,SCH MED,DEPT UROL,ABENO KU,OSAKA 545,JAPAN
[2] OSAKA PREFECTURAL INST PUBL HLTH,HIGASHINARI KU,OSAKA 537,JAPAN
来源
MUTATION RESEARCH | 1992年 / 269卷 / 02期
关键词
CYTOCHROME-P450; UMU GENE EXPRESSION; AFLATOXIN-B1;
D O I
10.1016/0027-5107(92)90204-F
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The genotoxic and mutagenic activation of aflatoxin B1 (AFB1) by hepatic, renal, and pulmonary microsomes and purified cytochrome P450s was investigated in Salmonella typhimurium TA1535/pSK1002 cells in which an umu response shows DNA damage. The activity of the hepatic microsomes was greatest. Pulmonary microsomes had moderate activity and renal microsomes had low activity. P450 2C11, 2B1, 3A2, 4A2, 4B1, K-2, and K-4 were assayed in a reconstituted system with dilauroylphosphatidylcholine (DLPC). P450 2C11 (a major hepatic cytochrome P450 in male rats) had high activity. P450 2B1 (a major form as well as P450 4B1 in pulmonary microsomes) and K-2 (a minor form in renal microsomes) had moderate activity. P450 4A2 (a major form in renal microsomes), P450 K-4 (a renal form), and P450 4B1 had low activity. P450 3A2 did not have high activity in these conditions but it had high activity toward AFB1 in a modified reconstituted system with a lipid mixture and sodium cholate instead of DLPC only. The activities of other forms were not enhanced by the modification of reconstituted system. Anti-P450 2C11 or 3A2 antibodies inhibited the bioactivation of AFB1 by hepatic microsomes to 50%. These results suggest that the greater ability of hepatic microsomes as compared with pulmonary and renal microsomes to metabolize AFB1 to mutagenic products is a function of the relative proportions of the highly active cytochrome P450s, P450 2C11 and 3A2, in the liver.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 50 条
  • [1] MUTAGENIC ACTIVATION OF AFLATOXIN-B1 BY SEVERAL FORMS OF PURIFIED CYTOCHROME-P-450
    ISHII, K
    MAEDA, K
    KAMATAKI, T
    KATO, R
    MUTATION RESEARCH, 1986, 174 (02): : 85 - 88
  • [2] CYTOCHROME-P-450 AND ACTIVATION OF AFLATOXIN-B1 IN SACCHAROMYCES-CEREVISIAE
    CALLEN, DF
    PHILPOT, RM
    ONG, TM
    MUTATION RESEARCH, 1978, 53 (01): : 85 - 85
  • [3] GENOTOXIC AND MUTAGENIC ACTIVATION OF AFLATOXIN-B1 BY CONSTITUTIVE FORMS OF CYTOCHROME-P-450 IN RAT-LIVER MICROSOMES
    SHIMADA, T
    NAKAMURA, SI
    IMAOKA, S
    FUNAE, Y
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 91 (01) : 13 - 21
  • [4] HEPATIC MITOCHONDRIAL CYTOCHROME-P-450 SYSTEM - DISTINCTIVE FEATURES OF CYTOCHROME-P-450 INVOLVED IN THE ACTIVATION OF AFLATOXIN-B1 AND BENZO(A)PYRENE
    NIRANJAN, BG
    WILSON, NM
    JEFCOATE, CR
    AVADHANI, NG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (20) : 2495 - 2501
  • [5] MUTAGENIC ACTIVATION OF AFLATOXIN-B1 BY P-450 HFLA IN HUMAN-FETAL LIVERS
    KITADA, M
    TANEDA, M
    OHI, H
    KOMORI, M
    ITAHASHI, K
    NAGAO, M
    KAMATAKI, T
    MUTATION RESEARCH, 1989, 227 (01): : 53 - 58
  • [6] AFLATOXIN-B1 METABOLISM BY 3-METHYLCHOLANTHRENE-INDUCED HAMSTER HEPATIC CYTOCHROME-P-450S
    LAI, TS
    CHIANG, JYL
    JOURNAL OF BIOCHEMICAL TOXICOLOGY, 1990, 5 (03): : 147 - 153
  • [7] PURIFICATION AND CHARACTERIZATION OF A HEPATIC MITOCHONDRIAL CYTOCHROME-P-450 ACTIVE IN AFLATOXIN-B1 METABOLISM
    SHAYIQ, RM
    AVADHANI, NG
    BIOCHEMISTRY, 1989, 28 (19) : 7546 - 7554
  • [8] SPECIFICITY OF RABBIT PULMONARY CYTOCHROME-P-450 ISOZYMES IN THE ACTIVATION OF SEVERAL AROMATIC-AMINES AND AFLATOXIN-B1
    ROBERTSON, IGC
    PHILPOT, RM
    ZEIGER, E
    WOLF, CR
    MOLECULAR PHARMACOLOGY, 1981, 20 (03) : 662 - 668
  • [9] AFLATOXIN-B1 ACTIVATION TO A PLASMID MUTAGEN BY A CHEMICAL-MODEL OF CYTOCHROME-P-450
    WOOD, ML
    SMITH, JRL
    GARNER, RC
    MUTATION RESEARCH, 1987, 176 (01): : 11 - 20
  • [10] METABOLISM-MEDIATED ACTIVATION OF AFLATOXIN-B1 (AFB1) BY DIFFERENT CYTOCHROME P-450S FROM PHENOBARBITAL (PB) TREATED RATS
    BANSAL, SK
    FUNG, PJ
    CABALLES, L
    GURTOO, HL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 113 - 113